Adenovirus types 4 and 7 live oral vaccine Approval Status beta

  • FDA approved: No
  • Generic name: adenovirus types 4 and 7 live oral vaccine
  • Company: Barr Pharmaceuticals, Inc.
  • Treatment for: Infection Prophylaxis

Adenovirus Types 4 and 7 Live Oral Vaccine is in development for the prevention of Adenovirus Type 4 and 7 associated acute respiratory disease.

FDA Approval Status for adenovirus types 4 and 7 live oral vaccine

DateArticle
Dec 11, 2008Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web4)